Literature DB >> 5064914

Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain.

C D Wise, B D Berger, L Stein.   

Abstract

The anxiety-reducing effects of minor tranquilizers in the rat conflict test were mimicked by serotonin antagonists and by p-chlorophenylalanine, an inhibitor of serotonin synthesis; the depressant effects of the minor tranquilizers were mimicked by norepinephrine antagonists. Intraventricular injections of serotonin led to a suppression of behavior, and also antagonized the anxiety-reducing action of benzodiazeprines. Intraventricular injections of norepinephrine led to a release of punished behavior from suppression, and also antagonized the depressant action of benzodiazepines. The anxiety-reducing activity, and the decrease in serotonin turnover induced by benzodiazepines, were maintained over repeated doses, whereas depressant activity, and the decrease induced in norepinephrine turnover, both rapidly underwent tolerance. Tranquilizers may exert their anxiety-reducing effects by a reduction of serotonin activity in a behaviorally suppressive punishment system, and they may exert their depressant effects by a reduction of norepinephrine activity in a behaviorally facilitatory reward system.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5064914     DOI: 10.1126/science.177.4044.180

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  58 in total

1.  Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.

Authors:  R A Agarwal; Y D Lapierre; R B Rastogi; R L Singhal
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

2.  Benzodiazepines: specific competitors for the binding of L-tryptophan to human serum albumin.

Authors:  W E Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Post-weaning social isolation of female rats, anxiety-related behavior, and serotonergic systems.

Authors:  Jodi L Lukkes; Glenn H Engelman; Naomi S Zelin; Matthew W Hale; Christopher A Lowry
Journal:  Brain Res       Date:  2012-01-12       Impact factor: 3.252

Review 4.  Sleep and hypnotic drugs.

Authors:  M W Johns
Journal:  Drugs       Date:  1975       Impact factor: 9.546

5.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.

Authors:  P Chopin; M B Assié; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients.

Authors:  A Weizman; S Tyano; H Wijsenbeek; M Ben David
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  A comparison between chlordiazepoxide and CL 218,872, a synthetic non-benzodiazepine ligand for benzodiazepine receptors, on serotonin and catecholamine turnover in brain.

Authors:  J F McElroy; R S Feldman; J S Meyer
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Effect of cyproheptadine and combinations of cyproheptadine and amphetamine on intermittently reinforced lever-pressing in rats.

Authors:  F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1976-10-20       Impact factor: 4.530

9.  Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement.

Authors:  J F McElroy; R S Feldman
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Long term effects of chronic chlordiazepoxide (CDP) administration.

Authors:  A Shemer; O Tykocinski; J Feldon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.